Placebos – MOSAEC

Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.

By Pam Belluck

Children and Childhood Clinical Trials Disease Rates Drugs (Pharmaceuticals) Food and Drug Administration Kennedy, Robert F Jr Medicine and Health Paralysis Placebos Regulation and Deregulation of Industry Research Salk, Jonas E Sanofi SA United States Vaccination and Immunization Viruses

What the Polio Vaccine Has Meant for Public Health

A lawyer working with Robert F. Kennedy Jr. has asked the F.D.A. to withdraw approval of the current shot because it hasn’t been tested against a placebo. Scientists say such a test would be unethical.

By Sheryl Gay Stolberg

Alzheimer's Disease Biogen Inc Brain Clinical Trials Dementia Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory Placebos Prices (Fares, Fees and Rates)

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

By Pam Belluck

Drug Abuse and Traffic Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration Institute for Clinical and Economic Review Justice Department Lykos Therapeutics Medicine and Health Mental Health and Disorders Multidisciplinary Assn for Psychedelic Studies Placebos Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Regulation and Deregulation of Industry Therapy and Rehabilitation Veterans

FDA Panel Rejects Use of MDMA for Treatment of PTSD

An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.

By Andrew Jacobs